GYRE THERAPEUTICS, INC. (GYRE)
Gyre Therapeutics, Inc. operates as a biopharmaceutical company. It is focused on the development and commercialization of Hydronidone (F351) for the treatment of Metabolic Dysfunction Associated Steatohepatitis (MASH-associated liver fibrosis). The firm operates through the BC and Gyre segments. The company was founded on March 7, 1997 and is headquartered in San Diego, CA.
Address
12770 HIGH BLUFF DRIVE, SUITE 150
SAN DIEGO, CA 92130
Founded
1997
Number of Employees
4
Website
http://www.gyretx.com
Insider Transactions
Filters
Keyboard Shortcuts: Show (a) | Close (Esc)